{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:29:27Z","timestamp":1775276967394,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T00:00:00Z","timestamp":1528675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Cosmo Technologies Ltd., Ireland"}],"content-domain":{"domain":["contemporaryclinicaltrials.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.cct.2018.06.001","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T21:50:27Z","timestamp":1527889827000},"page":"96-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Methylene blue MMX\u00ae tablets for chromoendoscopy. Bioavailability, colon staining and safety in healthy volunteers undergoing a full colonoscopy"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4316-9039","authenticated-orcid":false,"given":"A.F.D.","family":"Di Stefano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.M.","family":"Radicioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vaccani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Fransioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Moro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Repici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cct.2018.06.001_bb0005","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2036.2003.01445.x","article-title":"Gastrointestinal transit and 5-ASA release from a new mesalazine extended-release formulation","volume":"17","author":"Brunner","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.cct.2018.06.001_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2125.2005.02517.x","article-title":"January gastrointestinal transit, release and plasma pharmacokinetics of a new oral budesonide formulation","volume":"61","author":"Brunner","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.cct.2018.06.001_bb0015","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cct.2011.11.006","article-title":"Methylene blue MMX\u00ae tablets for chromoendoscopy. Safety tolerability and bioavailability in healthy volunteers","volume":"33","author":"Repici","year":"2012","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.cct.2018.06.001_bb0020","doi-asserted-by":"crossref","DOI":"10.1136\/gut.52.suppl_4.iv7","article-title":"Magnification endoscopy, high resolution endoscopy, and chromoscopy; towards a better optical diagnosis","volume":"52","author":"Bruno","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.cct.2018.06.001_bb0025","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1136\/gut.2004.061283","article-title":"In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy","volume":"54","author":"Becker","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.cct.2018.06.001_bb0030","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10620-005-1616-y","article-title":"Use of methylene blue for detection of specialized intestinal metaplasia in GERD patients presenting for screening upper endoscopy","volume":"50","author":"Duncan","year":"2005","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.cct.2018.06.001_bb0035","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1155\/1999\/763162","article-title":"Tissue staining (chromoscopy) of the gastrointestinal tract","volume":"13","author":"Fennerty","year":"1999","journal-title":"Can. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.cct.2018.06.001_bb0040","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0046-8177(91)90163-J","article-title":"Identification and quantification of aberrant crypt foci and microadenomas in the human colon","volume":"22","author":"Roncucci","year":"1991","journal-title":"Hum. Pathol."},{"issue":"7","key":"10.1016\/j.cct.2018.06.001_bb0045","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/ibd.20118","article-title":"Role of chromoendoscopy in colon cancer surveillance in inflammatory bowel disease","volume":"13","author":"Thorlacius","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.cct.2018.06.001_bb0050","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1586\/egh.12.65","article-title":"Advanced endoscopic imaging for dysplasia surveillance in ulcerative colitis","volume":"7","author":"Bessissow","year":"2013","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cct.2018.06.001_bb0055","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.gtc.2006.07.004","volume":"35","author":"Kiesslich","year":"2006","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"10.1016\/j.cct.2018.06.001_bb0060","series-title":"The Safety and Efficacy of Methylene Blue MMX\u00ae Modified Release Tablets Administered to Patients Undergoing Screening or Surveillance Colonoscopy","author":"Wallace","year":"2017"},{"key":"10.1016\/j.cct.2018.06.001_bb0065","series-title":"Colon Staining Efficacy of Single Oral Doses of Methylene Blue MMX\u00ae Modified Release Tablets Administered to Patients Undergoing Colonoscopy","author":"Repici","year":"2011"},{"key":"10.1016\/j.cct.2018.06.001_bb0070","series-title":"Intraepithelial Neoplasia Detection Rate after Single Oral Dose of Methylene Blue MMX\u00ae Modified Release Tablets Administered to Patients with Long Standing Ulcerative Colitis Undergoing Colonoscopy","author":"Danese","year":"2012"},{"key":"10.1016\/j.cct.2018.06.001_bb0075","doi-asserted-by":"crossref","unstructured":"A. Repici, Polyp Detection Rate after Single Oral Dose of Methylene Blue MMX\u00ae Modified Release Tablets Administered to Subjects Undergoing Outpatients Colonoscopy. Cosmo Technologies, Ireland, 2012, https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01520337?term=methylene+blue+MMX&rank=5 (ClinicalTrials.gov Identifier: NCT01520337).","DOI":"10.1016\/j.gie.2013.04.137"},{"key":"10.1016\/j.cct.2018.06.001_bb0095","unstructured":"ICH harmonised tripartite guideline. Non-clinical safety studies for the conduct of human clinical trials for pharmaceuticals M3(R1), recommended for adoption at step 4 of the ICH process on 16 July 1997 and amended on 9 November 2000 by the ICH steering committee."},{"key":"10.1016\/j.cct.2018.06.001_bb0100","series-title":"Nutrition and Your Health: Dietary Guidelines for Americans","author":"U.S. Department of Health and Human Services and U.S. Department of Agriculture","year":"2005"},{"key":"10.1016\/j.cct.2018.06.001_bb0120","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/gut.27.8.886","article-title":"Transit of pharmaceutical dosage forms through the small intestine","volume":"27","author":"Davis","year":"1986","journal-title":"Gut"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714418300302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714418300302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T20:46:00Z","timestamp":1571431560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714418300302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":18,"alternative-id":["S1551714418300302"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2018.06.001","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methylene blue MMX\u00ae tablets for chromoendoscopy. Bioavailability, colon staining and safety in healthy volunteers undergoing a full colonoscopy","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2018.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}